News

The mood at the annual meeting of the American Society of Cell and Gene Therapy isn’t amazing. The biotech market has been ...
Ex-FDA chief Robert Califf about HHS Secretary Robert F. Kennedy Jr. — “My primary worry is not the FDA, my worry is the ...
The scientists at the University of California, San Francisco and Johns Hopkins University in Baltimore injected an antisense ...
If 14 million lost coverage, that would push the total number of uninsured in the U.S. close to pre-Affordable Care Act ...
A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...
GOP lawmakers tested the limits of how far they could push Kennedy without appearing to undermine him or his MAHA movement.
Tucked inside President Trump's executive order on drug pricing is a sentence that appears to threaten the FDA could yank ...
But multiple federal reports indicated that the law fell short, as insurance companies routinely exploited loopholes to avoid ...
GSK plans to purchase an experimental drug for the liver disease MASH from Boston Pharmaceuticals for $1.2 billion upfront.
Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year moratorium on ...
U.S. drug overdose deaths fell 27% in 2024, the lowest since 2019, with fentanyl cases sharply down but methamphetamine up, ...
Tucked inside Trump's drug-pricing executive order is an apparent threat to withdraw drugmakers' medicines if they do not ...